Claims
- 1. A method for producing optically-active 2-piperazinecarboxylic acid derivatives, which comprises optically resolving 2-piperazinecarboxylic acid derivatives with a resolving reagent of optically-active acidic amino acid derivatives.
- 2. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 1, wherein the salt concentration is not lower than 25% by weight.
- 3. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 1 or 2, wherein the optically-active acidic amino acid derivatives are represented by the following general formula (I): ##STR6## wherein R.sup.1 represents i) a hydrogen atom, ii) an unsubstituted or halogen-substituted, linear or branched alkyl group having from 1 to 10 carbon atoms, iii) an unsubstituted aryl group, or an aryl group substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a halogen atom or a hydroxyl group, iv) an aralkyl group of which the aromatic ring moiety is unsubstituted or substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a halogen atom or a hydroxyl group, or v) an aralkyloxy group of which the aromatic ring moiety is unsubstituted or substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a halogen atom or a hydroxyl group; and n represents 1 or 2, or by the general formula II: ##STR7## wherein R.sup.2 represents i) an unsubstituted or halogen-substituted, linear or branched alkyl group having from 1 to 10 carbon atoms, ii) an unsubstituted aryl group, or an aryl group substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a halogen atom or a hydroxyl group, or iii) an aralkyl group of which the aromatic ring moiety is unsubstituted or substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a halogen atom or a hydroxyl group; and n represents 1 or 2.
- 4. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 3, wherein the optically-active acidic amino acid derivatives are represented by the following general formula (III): ##STR8## wherein R.sup.3 represents i) a hydrogen atom, ii) a linear or branched alkyl group having from 1 to 4 carbon atoms, iii) a nitro group, or iv) a halogen atom; and n represents 1 or 2.
- 5. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 3, wherein the 2-piperazinecarboxylic acid derivatives are represented by the following general formula (IV): ##STR9## wherein R.sup.4 and R.sup.5 may be the same or different, and each represents i) a hydrogen atom, ii) an alkyl group having from 1 to 10 carbon atoms, iii) an unsubstituted aryl group, or an aryl group substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a nitro group or a halogen atom, or iv) an aralkyl group of which the aromatic ring moiety is unsubstituted or substituted by an alkyl group having from 1 to 10 carbon atoms, an alkoxyl group having from 1 to 10 carbon atoms, a nitro group or a halogen atom; and tBu represents a tert-butyl group.
- 6. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 5, wherein the 2-piperazinecarboxylic acid derivative is a compound of the following formula (VI): ##STR10## wherein tBu represents a tert-butyl group.
- 7. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 1, wherein the resolution solvent is water, or an alcohol, or a mixed solvent of water and an alcohol.
- 8. The method for producing optically-active 2-piperazinecarboxylic acid derivatives as claimed in claim 1, wherein the molar ratio of the resolving reagent to the 2-piperazinecarboxylic acid derivative is from 0.4/1 to 1.1/1.
Parent Case Info
This application is a 371 of PCT/JP96/03864 filed Dec. 27, 1996.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/JP96/03864 |
12/27/1996 |
|
|
8/26/1998 |
8/26/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO98/29398 |
7/9/1998 |
|
|
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5413999 |
Vacca et al. |
May 1995 |
|